Ivermectin and onchocerciasis: is it all solved? (Q36320403)

13 August 2017

1 reference

title

Ivermectin and onchocerciasis: is it all solved? (English)

1 reference

13 August 2017

0 references

0 references

Hopkins AD

1

1 reference

PubMed ID

16304585

13 August 2017

language of work or name

1 reference

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

19

1 reference

13 August 2017

1057-1066

1 reference

13 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701962

13 August 2017

0 references

cites work

Blindness and visual impairment in a region endemic for onchocerciasis in the Central African Republic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

Onchocerciasis and epilepsy: a matched case-control study in the Central African Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

Mectizan Donation Program: evaluation of a public-private partnership

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

Impact of ivermectin on illness and disability associated with onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

Ten years of NGDO action against river blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

Medical achievements under civil war conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

The achievements and challenges of the African Programme for Onchocerciasis Control (APOC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

Onchocercal eye disease and the impact of Mectizan treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of three-month doses of ivermectin on adult Onchocerca volvulus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701962

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.EYE.6701962

1 reference

13 August 2017

1 reference

PubMed ID

16304585